Cryptococcus | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

69 results for “Cryptococcus”

Trials

View all 65 →

Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Cryptococcus Neoformans Infection in Patients Not Infected With HIV and Complications Associated With Cryptococcus Neoformans Infection

300 participants · First posted Nov 4, 1999

Operational Research for Cryptococcal Antigen Screening

3,049 participants · First posted Feb 17, 2012

Dexamethasone in Cryptococcal Meningitis

36 participants · First posted Aug 31, 2001

Drugs

Flucytosine(Ancobon)

Conditions: Candidiasis, Candidiasis, Systemic +7 more

C₄H₄FN₃O · Rx

News

Mycovia Pharmaceuticals Initiates Phase 2 Trial of Oteseconazole for Cryptococcal Meningitis

£17.9 Million Wellcome Grant Funds Major Initiative to Combat Deadly Fungal Infections

New Sustained-Release Flucytosine Enters Phase II Trials for Cryptococcal Meningitis Amid HIV Funding Crisis

Page 1 of 7